Association Between High-Sensitivity C-Reactive Protein and Longitudinal Changes in Arteriosclerosis Over Time: The Kailuan Prospective Cohort Study

高敏C反应蛋白与动脉粥样硬化纵向变化的相关性:开滦前瞻性队列研究

阅读:1

Abstract

OBJECTIVE: To investigate the relationship between high-sensitivity C-reactive protein (hs-CRP) and the longitudinal changes in arterial Arteriosclerosis over time. METHODS: Using a prospective cohort study design, 25,336 participants from the Kailuan study cohort, who had completed at least two baPWV measurements and met the inclusion criteria, included in the analysis. Participants were divided into three groups based on baseline hs-CRP levels: hs-CRP<1 mg/L, 1 mg/L≤hs-CRP≤3 mg/L, and hs-CRP >3 mg/L. The relationship between hs-CRP and the longitudinal changes in baPWV was analyzed using a linear mixed-effects model. RESULTS: (1) The average follow-up duration was 4.62 ± 2.86 years. At the end of the follow-up, the baPWV of the three groups:hs-CRP < 1 mg/L (n=11,651), 1 mg/L ≤ hs-CRP ≤ 3 mg/L (n=9,369), and hs-CRP > 3 mg/L (n=4,316) increased over time. The average rate of increase in baPWV was 84.26 cm/s, 88.06 cm/s, and 73.92 cm/s, respectively. (2) The linear mixed-effects model analysis of factors affecting the progression of Arteriosclerosis, after adjusting for confounding factors, showed that compared to the hsCRP_1 group, the baPWV increase rate in the hsCRP_2 and hsCRP_3 groups was progressively higher. The effect Estimate were 14.4 cm/s (95% CI 6.54 to 22.34, P<0.001) and 40.67 cm/s (95% CI 5.28 to 51.02, P<0.001), respectively. Stratifying by gender showed that the impact was more pronounced in males, with effect Estimate of 20.56 cm/s (95% CI 6.18 to 8.45, P<0.001) and 43.06 cm/s (95% CI 27.82 to 58.31, P<0.001), respectively. Sensitivity analysis confirmed that this longitudinal association was more pronounced. CONCLUSION: There is a significant "dose-response" relationship between hs-CRP and the longitudinal progression of Arteriosclerosis, with a more pronounced effect observed in the male population.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。